[Sar,D-Phe8,des-Arg9]bradykinin [7073]
[Sar,D-Phe8,des-Arg9]bradykinin
| SMILES |
CNCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@H](Cc1ccccc1)C(=O)O |
| InChIKey |
YIUBSFCQATYQJB-VCMDLEIESA-N |
| Sequence |
XRPPGFSPF |
| HELM |
PEPTIDE1{[Sar].R.P.P.G.F.S.P.[dF]}$$$$ |
Chemical Properties
| Hydrogen bond acceptors |
12 |
| Hydrogen bond donors |
10 |
| Rotatable bonds |
24 |
| Log P |
-3.150 |
| Molecular weight (Da) |
974.5 |
| Stereochemistry info |
unspecified |
Bioactivities
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
|
| Receptor |
Activity |
Source |
| Protein |
Gene |
Species |
Family |
Class |
Type |
Min |
Avg |
Max |
Database |
|
|
|
|
|
|
|
|
|
|
[Sar,D-Phe8,des-Arg9]bradykinin
Drug properties
| Molecular type |
Peptide |
| Physiological/Surrogate |
Surrogate |
| Approved drug |
No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Compound is not listed as a drug.